Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 10, 2024Applied SciencesOpen Access

1-Deoxynojirimycin Attenuates High-Glucose-Induced Oxidative DNA Damage via Activating NRF2/OGG1 Signaling

View Full Paper
Ask AI
Bookmark
Share

Authors

YCYuwei ChenJWJun Wang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chen et al. (2024) studied this question.

synapsesocial.com/papers/68e6fa83b6db643587674680https://doi.org/10.3390/app14083186
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Therapeutic Prospects of Mulberry-Derived DNJ: A Review2025
  2. 2Critical Review of 1-Deoxynojirimycin (DNJ) 
in Mulberry in Curing Diabetes Mellitus2025
  3. 3Metabolic Modulation of Type 2 Diabetes Mellitus by 1-Deoxynojirimycin: A Multifaceted Approach2026 · 1 citations
  4. 4Activity-based proteomics analysis revealed that DNJ directly targeted ATP5F1 to alleviate high glucose induced cardiomyocyte injury2026
  5. 51‐Deoxynojirimycin attenuates pathological markers of Alzheimer's disease in the in vitro model of neuronal insulin resistance2024 · 8 citations